리네졸리드와 반코마이신을 교대로 투여하여 치료한 지속성 메티실린 내성 황색포도알균 균혈증 1예 = Alternating Linezolid-Vancomycin Therapy for Persistent Endovascular Methicillin-resistant Staphylococcus aureus Infection: A Case Report

다국어 초록 (Multilingual Abstract)

Persistent Staphylococcus aureus bacteremia is frequently defined as bacteremia persisting for ≥7 days despite proper antibiotic therapy. Its treatment includes removal of all infection foci and proper antibiotic therapy. Vancomycin remains the antibiotic of choice in MRSA bacteremia. Alternative agents, linezolid or daptomycin, are available, but a consensus regarding management of persistent MRSA bacteremia on vancomycin failure is still lacking. We report a case of a 60-year-old male who received thoracoabdominal aorta replacement operation due to dissecting aneurysm of the ascending and descending aorta. Surgical site infection and bacteremia caused by MRSA occured, and wound debridement operations were performed. The patient was treated with vancomycin in therapeutic doses but MRSA bacteremia persisted for 168 days in a row. Although the inserted aortic graft was the most probable source of persistent bacteremia, surgical removal was impossible. Linezolid was administered as an alternative antibiotic but had to be discontinued from time to time due to thrombocytopenia induced by this agent. In the end, MRSA bacteremia was successfully managed by alternating vancomycin-linezolid therapy.

참고문헌 (Reference)

1 문수연, "포도알균 균혈증 환자에서 사망 예측 위험인자" 대한감염학회 40 (40): 148-153, 2008

2 Sakoulas G, "antibiotic resistance among methicillin-resistant Staphylococcus aureus strains" 5 : S360-S367, 2008

3 Orrick JJ, "Thrombocytopenia secondary to linezolid administration: what is the risk?" 35 : 348-349, 2002

4 Attassi K, "Thrombocytopenia associated with linezolid therapy" 34 : 695-698, 2002

5 Siegman-Igra Y, "The role of vancomycin in the persistence or recurrence of Staphylococcus aureus bacteraemia" 37 : 572-578, 2005

6 Lowy FD, "Staphylococcus aureus infections" 339 : 520-532, 1998

7 Jang HC, "Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem" 49 : 395-401, 2009

8 Sakoulas G, "Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia" 42 : 2398-2402, 2004

9 Fowler VG Jr, "Persistent bacteremia due to methicillin- resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein" 190 : 1140-1149, 2004

10 Hawkins C, "Persistent Staphylococcus aureus bacteremia: an analysis of risk factors and outcomes" 167 : 1861-1867, 2007

11 Cosgrove SE, "Optimizing therapy for methicillin-resistant Staphylococcus aureus bacteremia" 28 : 624-631, 2007

12 Cosgrove SE, "Management of methicillin-resistant Staphylococcus aureus bacteremia" 5 : S386-S393, 2008

13 Falagas ME, "Linezolid versus glycopeptide or beta-lactam for treatment of Gram- positive bacterial infections: meta-analysis of randomised controlled trials" 8 : 53-66, 2008

14 Wilcox MH, "Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study" 48 : 203-212, 2009

15 Micek ST, "Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections" 3 : S184-190, 2007